Mira Pharmaceuticals Common Stock Market Value
| MIRA Stock | 1.19 0.01 0.83% |
| Symbol | MIRA |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals. Expected growth trajectory for MIRA significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MIRA Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding MIRA Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects MIRA's accounting equity. The concept of intrinsic value - what MIRA Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MIRA Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that MIRA Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MIRA Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MIRA Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
MIRA Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MIRA Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MIRA Pharmaceuticals.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in MIRA Pharmaceuticals on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding MIRA Pharmaceuticals Common or generate 0.0% return on investment in MIRA Pharmaceuticals over 90 days. MIRA Pharmaceuticals is related to or competes with Myomo, Talphera, Apimeds Pharmaceuticals, Precision Optics, Milestone Scientific, India Globalization, and Modular Medical. MIRA Pharmaceuticals is entity of United States More
MIRA Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MIRA Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MIRA Pharmaceuticals Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 15.4 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 3.6 |
MIRA Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MIRA Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MIRA Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use MIRA Pharmaceuticals historical prices to predict the future MIRA Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.43) |
MIRA Pharmaceuticals February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 2.22 | |||
| Coefficient Of Variation | (790.72) | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.81 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 15.4 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 3.6 | |||
| Skewness | 0.0088 | |||
| Kurtosis | 0.8365 |
MIRA Pharmaceuticals Backtested Returns
MIRA Pharmaceuticals has Sharpe Ratio of -0.0869, which conveys that the firm had a -0.0869 % return per unit of volatility over the last 3 months. MIRA Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MIRA Pharmaceuticals' risk adjusted performance of (0.09), and Mean Deviation of 2.22 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.9, which conveys possible diversification benefits within a given portfolio. MIRA Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, MIRA Pharmaceuticals is expected to follow. At this point, MIRA Pharmaceuticals has a negative expected return of -0.26%. Please make sure to verify MIRA Pharmaceuticals' day median price, period momentum indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if MIRA Pharmaceuticals performance from the past will be repeated at future time.
Auto-correlation | -0.78 |
Almost perfect reverse predictability
MIRA Pharmaceuticals Common has almost perfect reverse predictability. Overlapping area represents the amount of predictability between MIRA Pharmaceuticals time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MIRA Pharmaceuticals price movement. The serial correlation of -0.78 indicates that around 78.0% of current MIRA Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.78 | |
| Spearman Rank Test | -0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals Common Stock:Check out MIRA Pharmaceuticals Correlation, MIRA Pharmaceuticals Volatility and MIRA Pharmaceuticals Performance module to complement your research on MIRA Pharmaceuticals. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
MIRA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.